Literature DB >> 8010935

Ischaemic ATP degradation studied by HPLC and 31P-NMR spectroscopy: do the two techniques observe the same ATP pools?

P Herijgers1, K Overloop, Y Toshima, P Van Hecke, F Vanstapel, K Mubagwa, W Flameng.   

Abstract

31P-NMR spectroscopy has become the major tool for studying myocardial high energy phosphates. Conflicting results concerning NMR visibility of ATP in ischaemic myocardium were reported. A detailed study was undertaken to resolve this controversy. After cardioplegic arrest, canine hearts were excised and preserved for 24 h at 1 degree C (group 1) or for 6h at 23 degrees C (group 2). ATP breakdown was followed by 31P-NMR spectroscopy in a transmural piece of the anterior wall introduced in the NMR magnet, and by HPLC analysis using serial transmural biopsies from the rest of the anterior wall. At both temperatures, identical relative ATP decay curves were obtained, whether measured by NMR or by HPLC. Absolute quantification of ATP was carried out after varying periods of ischaemia at 1 degree C. The NMR-measured ATP concentration was 106 +/- 8% of the ATP concentration determined by HPLC. From our experiments, we conclude that ATP visibility for 31P-NMR spectroscopy is complete and constant during prolonged periods of hypothermic ischaemia in canine hearts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8010935     DOI: 10.1007/bf00788677

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  18 in total

1.  Cytosolic adenylates and adenosine release in perfused working heart. Comparison of whole tissue with cytosolic non-aqueous fractionation analyses.

Authors:  R Bünger; S Soboll
Journal:  Eur J Biochem       Date:  1986-08-15

Review 2.  Magnetic resonance spectroscopy of the heart. Overview of studies in animals and man.

Authors:  C B Higgins; M Saeed; M Wendland; W M Chew
Journal:  Invest Radiol       Date:  1989-12       Impact factor: 6.016

3.  NMR observability of ATP: preferential depletion of cytosolic ATP during ischemia in perfused rat liver.

Authors:  E Murphy; S A Gabel; A Funk; R E London
Journal:  Biochemistry       Date:  1988-01-26       Impact factor: 3.162

4.  31P NMR and enzymatic analysis of cytosolic phosphocreatine, ATP, Pi and intracellular pH in the isolated working perfused rat heart.

Authors:  G P Dobson; R L Veech; J V Passonneau; K Kobayashi; T Inubushi; S Wehrli; S Nioka; B Chance
Journal:  NMR Biomed       Date:  1992 Jan-Feb       Impact factor: 4.044

5.  Adenine nucleotide metabolism and compartmentalization in isolated adult rat heart cells.

Authors:  T Geisbuhler; R A Altschuld; R W Trewyn; A Z Ansel; K Lamka; G P Brierley
Journal:  Circ Res       Date:  1984-05       Impact factor: 17.367

6.  Evidence that ischemic cell death begins in the subendocardium independent of variations in collateral flow or wall tension.

Authors:  J E Lowe; R G Cummings; D H Adams; E A Hull-Ryde
Journal:  Circulation       Date:  1983-07       Impact factor: 29.690

7.  Phosphorus-31 nuclear-magnetic-resonance study of phosphorylated metabolites compartmentation, intracellular pH and phosphorylation state during normoxia, hypoxia and ethanol perfusion, in the perfused rat liver.

Authors:  F Desmoulin; P J Cozzone; P Canioni
Journal:  Eur J Biochem       Date:  1987-01-02

8.  Effect of ischemia on NMR detection of phosphorylated metabolites in the intact rat heart.

Authors:  F M Jeffrey; C J Storey; R L Nunnally; C R Malloy
Journal:  Biochemistry       Date:  1989-06-27       Impact factor: 3.162

9.  Activity of phosphorylase in total global ischaemia in the rat heart. A phosphorus-31 nuclear-magnetic-resonance study.

Authors:  I A Bailey; S R Williams; G K Radda; D G Gadian
Journal:  Biochem J       Date:  1981-04-15       Impact factor: 3.857

10.  Is cellular integrity responsible for the partial NMR invisibility of ATP in isolated ischemic rat liver?

Authors:  J L Gallis; M C Delmas-Beauvieux; M Biran; N Rousse; T Durand; P Canioni
Journal:  NMR Biomed       Date:  1991-12       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.